FDA Inspection
Blair M. Brengle, M.D.Blair M. Brengle, M.D. – FDA Inspection, Aug 29, 2024
Record Details
This FDA Inspection record concerns Blair M. Brengle, M.D., with an inspection on August 29, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f6682fb3-81e0-4c30-8951-16984b32103f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1247858
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.64(b)Safety Reports - Non-Serious Events
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Blair M. Brengle, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 8, 2021 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Blair M. Brengle, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.